Back to search

Article

N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway

2022-08-23

Abstract excerpt

<h4>Background: </h4> Pancreatic cancer (PC) is highly malignant. Chemotherapy is the main treatment strategy, especially for patients with advanced PC. However, chemoresistance has always been a frequently encountered bottleneck. Hence, there is an urgent need to enhance the sensitivity of PC to gemcitabine (GEM). <h4>Results: </h4>: We demonstrated that SH3BP5-AS1 was significantly upregulated in GEM-resistant P...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be92d573-8908-51e5-be2a-821eaf09c24a
DOI
10.21203/rs.3.rs-1926149/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathwayDOI 10.21203/rs.3.rs-1926149/v1
Select a neighboring publication to make it the new centre.